Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
US9586965B2 · kind B2 · utility
7Cited by
7References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2013 |
| Grant date | Mar 7, 2017 |
| Priority date | — |
| Expiry date | Jul 11, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to certain pyrrolopyrimidine derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3(D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.